According to an FDA press release that came out earlier this week, the numbing agent Benzocaine can cause breathing problems, rapid heartbeat, and headaches in babies.

The report is adding to its previous warning that Baby Orajel, Cepacol, Anbesol, Chloraseptic, and other name brand products, contains elevated levels of methemoglobinemia that leads to death.

The director of the FDA's Center for Drug Evaluation and Research Dr. Janet Woodcock said:

“Given the accumulating evidence regarding benzocaine’s association with methemoglobinemia, we are taking necessary action to work with industry to discontinue the distribution and sale of over-the-counter benzocaine oral health products intended for teething pain, and add warning information about methemoglobinemia and a contraindication against use for teething pain and against use in children under two years of age to the remaining oral health care drug products containing benzocaine,”

The press release also states that the FDA is taking necessary action to work with the industry to discontinue the distribution of Benzocaine.

Amazon

 

Join Our Newsletter Here. 

Download Our App here for Android.

Download Our App here for iPhone.